Regulation of endogenous gene expression using small molecule-controlled engineered zinc-finger protein transcription factors
- 19 July 2007
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 14 (18) , 1362-1369
- https://doi.org/10.1038/sj.gt.3302985
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemiaJournal of Vascular Surgery, 2006
- Designer zinc-finger proteins and their applicationsGene, 2005
- Towards therapeutic applications of engineered zinc finger proteinsFEBS Letters, 2004
- Engineered Zinc Finger–Activating Vascular Endothelial Growth Factor Transcription Factor Plasmid DNA Induces Therapeutic Angiogenesis in Rabbits With Hindlimb IschemiaCirculation, 2004
- Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular diseaseExpert Opinion on Investigational Drugs, 2004
- Engineered Zinc Finger Proteins for Controlling Stem Cell FateThe International Journal of Cell Cloning, 2003
- Synthetic Zinc Finger Transcription Factor Action at an Endogenous Chromosomal SiteJournal of Biological Chemistry, 2000
- Ligand-Dependent Regulation of Plasmid-Based Transgene Expression in VivoHuman Gene Therapy, 1999
- Ecdysone-inducible gene expression in mammalian cells and transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Negative effect of the transcriptional activator GAL4Nature, 1988